Flow-through test: Difference between revisions

Revision as of 19:20, 22 September 2013

Revision as of 14:22, 10 March 2016

Line 1:

{{Orphan|date=September 2013}}

'''Flow-through tests''' are a type of diagnostic assay that allows users to test for the presence of a biomarker, usually a specific [[antibody]], in a sample such as blood. Detection of a specific biomarker aids in the diagnosis of and allows therapeutic action to be initiated quickly. The field of applications for this technology is wide, whereas generally all applications applying [[lateral flow test]]s can be replaced by flow-through assays. Commercial applications mainly target testing for infectious disease, both by viruses (e.g. [[HIV]], [[Hepatitis C]], [[Hepatitis B]] <ref name="medmira">http://www.medmira.com/default.asp?mn=1.21.83.113products</ref>

) or bacteria (e.g. [[Syphilis]]<ref name="medmira_a">http://www.medmira.com/default.asp?mn=1.21.168.169</ref>

or [[Helicobacter pylori]] <ref name="medmira_b">http://www.medmira.com/default.asp?mn=1.21.82</ref>).